VERBESSERTE POXVIRENIMPFSTOFFE

Patent europeic · EP2968493 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2968493
Numer da la dumonda
EP14723475
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
14-03-2014
Publitgà
20-01-2016
Concedì
13-06-2018
Stritgà
23-10-2025
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/00 (2006.01)
C07K 14/705 (2006.01)
C07K 14/74 (2006.01)
C07K 14/005 (2006.01)
Prioritad
WO PCT/EP2013/055409 15.03.2013
Dumonda PCT
PCT/IB2014/059802 14.03.2014
Publicaziun PCT
WO2014/141176 18.09.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2025

  2. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  3. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  4. 09-08-2018

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 09.08.2018

  5. 13-06-2018

    Concedì

    Published in Swissreg on 13.06.2018

Partidas

Possessur

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

COLLOCA, Stefano

00144 Rome, IT

CORTESE, Riccardo

4051 Basel

FOLGORI, Antonella

00144 Rome, IT

NICOSIA, Alfredo

00144 Rome, IT

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.